VC valuations slump persists
VC valuations continued to slide from their peaks in 2021 and early 2022, with only pre-seed and seed deals bucking the trend. While median early-stage and late-stage valuations fell to their three- and five-year lows, respectively, an abundance of small funds competing for seed deals helped to keep prices up for companies in those categories.
Not only did 2023 see a dismally low number of IPOs, but the median valuation of startups that managed to make a public debut declined to the lowest level in a decade. Although M&A activity dropped too, acquisition valuations increased year-over-year, according to our 2023 Annual US VC Valuations Report, sponsored by Morgan Stanley At Work and Mintz.
Table of contents
| Key takeaways | 4 |
| Pre-seed and seed valuations | 5 |
| Early-stage VC valuations | 7 |
| Late-stage VC valuations | 10 |
| Venture-growth valuations | 12 |
| A word from Morgan Stanley At Work | 14 |
| AI | 16 |
| Biopharma | 18 |
| A word from Mintz | 20 |
| Nontraditional investors | 22 |
| Liquidity | 24 |
| Deal terms | 26 |